Search

Search Constraints

You searched for: Author/Creator Hedley, Ann

Search Results

1. CXCR2 inhibition enables NASH-HCC immunotherapy. Issue 10 (27th April 2022)

2. E‐cadherin can limit the transforming properties of activating β‐catenin mutations. (3rd August 2015)

3. Phase II proof‐of‐concept study of atorvastatin in castration‐resistant prostate cancer. (12th August 2022)

4. Selection of established tumour cells through narrow diameter micropores enriches for elevated Ras/Raf/MEK/ERK MAPK signalling and enhanced tumour growth. (4th July 2021)

5. Sprouty2 loss‐induced IL6 drives castration‐resistant prostate cancer through scavenger receptor B1. Issue 4 (14th March 2018)